We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA, CMS Hope Parallel Review Spurs New Drug Development
FDA, CMS Hope Parallel Review Spurs New Drug Development
September 17, 2010
The FDA and the Centers for Medicare & Medicaid Services (CMS) are another step closer to establishing a parallel review process for new drugs by opening a docket for public comment on the proposed activity.